Table 4.

Adjusted odds ratios (ORs) and 95% confidence intervals (CIs) of sarcopenic obesity by quartiles of ω3FA ratio.

Males	Q1	Q2	Q3	Q4
	(<0.4)	(0.4–<0.7)	(0.7–<1.1)	(≥1.1)
Model 1	1 (ref)	1.288 (0.776–2.138)	1.298 (0.804–2.097)	1.118 (0.701–1.782)
Model 2	1 (ref)	1.668 (0.868–3.205)	1.160 (0.592–2.272)	1.000 (0.512–1.953)
Model 3	1 (ref)	1.563 (0.802–3.047)	1.246 (0.611–2.542)	0.924 (0.458–1.864)
Females	Q1	Q2	Q3	Q4
	(<0.4)	(0.4–<0.7)	(0.7–<1.2)	(≥1.2)
Model 1	1 (ref)	0.807 (0.534–1.221)	0.847 (0.552–1.299)	0.603 (0.376–0.967)
Model 2	1 (ref)	0.604 (0.355–1.028)	0.649 (0.394–1.072)	0.282 (0.129–0.617)
Model 3	1 (ref)	0.663 (0.379–1.160)	0.640 (0.372–1.102)	0.246 (0.113–0.534)

Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using weighted multivariate logistic regression analyses. Model 1: Adjusted for age. Model 2: Adjusted for age, BMI, total cholesterol, systolic blood pressure, fasting plasma glucose, AST, and hsCRP. Model 3: Adjusted for current smoking status, heavy alcohol intake, economic status, marital status, education duration, occupation, sufficient physical activity, history of diabetes mellitus, history of hypertension, and protein intake in addition to variables of Model 2. Abbreviation: ω3FA ratio, ratio of daily ω3FA intake to energy intake; AST, aspartate transaminase; hsCRP, high-sensitivity C-reactive protein.